Postoperative transhepatic arterial chemoembolization and portal vein chemotherapy for patients with hepatocellular carcinoma: A randomized study with 131 cases

Digestive Surgery

Volumn 23, Issue 4, 2006, Pages 235-240

  Li, Q ^a   Wang, J ^a   Sun, Y ^a   Cui, Y L ^a   Juzi, J T ^a   Qian, B Y ^a   Hao, X S ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Portal vein chemotherapy; Transarterial chemoembolization

Indexed keywords

CARBOPLATIN; CISPLATIN; DOXORUBICIN; FLUOROURACIL; HEPARIN; MITOMYCIN;

ABDOMINAL DISCOMFORT; ADULT; AGED; ANOREXIA; ARTICLE; ASCITES; BLEEDING; CANCER CHEMOTHERAPY; CATHETER OCCLUSION; CHEMOEMBOLIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FEVER; FOLLOW UP; HEMATOMA; HUMAN; INFECTION; LEUKOPENIA; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; NAUSEA; PORTAL VEIN; POSTOPERATIVE PERIOD; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTOPENIA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CISPLATIN; COMBINED MODALITY THERAPY; DOXORUBICIN; FEMALE; FLUOROURACIL; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MITOMYCIN; PORTAL VEIN; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL RATE;

EID: 33750444939     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095396     Document Type: Article

References (25)

1. Zhang JY, Dai M, Wang X, Lu WQ: A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China. Int J Epidemiol 1998;27:574-578.
2. Chung YH, Song H, Song BC, Lee GC, Koh MS, Yoon HK, Lee YS, Sung KB, Suh DJ: Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-α for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis. Cancer 2000;88:1986-1991.
3. Qiang L, Huikai L, Butt K, Wang PP, Hao X: Factors associated with disease survival after surgical resection in Chinese patients with hepatocellular carcinoma. World J Surg 2006;30:439-445.
4. Momosaki S, Nakashima Y, Kojiro M, Tabor E: HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma. J Viral Hepat 2005;12:325-329.
5. Tokita H, Fukui H, Tanaka A, Kamitsukasa H, Yagura M, Harada H, Okamoto H: Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy. J Gastroenterol Hepatol 2005;20:752-758.
6. Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A: Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993;218:145-151.
7. Nagasue N, Uchida M, Makino Y, Takemoto Y, Yamanoi A, Hayashi T, Chang YC, Kohno H, Nakamura T, Yukaya H: Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 1993;105:488-494.
8. Tsai TJ, Chau GY, Lui WY, Tsay SH: Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 2000;127:603-608.
9. Friedman M: Primary hepatocellular cancer-present results and future prospects. Int J Radiat Oncol Biol Phys 1983;9:1841-1850.
10. Iwamiya T, Sawada S, Ohta Y: Repeated arterial infusion chemotherapy for inoperable hepatocellular carcinoma using an implantable drug delivery system. Cancer Chemother Pharmacol 1994;33(suppl):S134-S138.
11. Une Y, Uchino J, Yasuhara M, Misawa K, Kamiyama T, Shimamura T, Sato N, Nakajima Y, Hata Y: Intra-arterial infusion chemotherapy on unresectable hepatocellular carcinoma under occlusion of hepatic arterial flow. Clin Ther 1993;15:347-354.
12. Lin Z, Ren Z, Xia J: Appraisal of postoperative transcatheter arterial chemoembolization (TACE) for prevention and treatment of hepatocellular carcinoma recurrence (in Chinese). Zhonghua Zhong Liu Za Zhi 2000;22:315-317.
13. Toyoda H, Nakano S, Kumada T, Takeda I, Sugiyama K, Osada T, Kiriyama S, Suga T, Takahashi M: The efficacy of continuous local arterial infusion of 5-fluorouracil and cisplatin through an implanted reservoir for severe advanced hepatocellular carcinoma. Oncology 1995;52:295-299.
14. Li Q, Hao XS, Zhang ZG, Song TQ, Hao JH, Ma WD, Sun T, Wang DC: Clinical value of portal vein chemotherapy in treatment of hepatocellular carcinoma with tumor thrombosis of main trunk of portal vein. Chin J Hepatobil Surg 2002;7:420-421.
15. Fujii T, Takayasu K, Muramatsu Y, Moriyama N: Hepatocellular carcinoma with portal tumor thrombus: analysis of factors determining prognosis. Jpn J Clin Oncol 1993;23:105-109.
16. Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso Mdel C, Sala M, Bru C, Rodes J, Bruix J: Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 1999;29:62-67.
17. Sangro B, Rios R, Bilbao I, Beloqui O, Herrero JI, Quiroga J, Prieto J: Efficacy and toxicity of intra-arterial cisplatin and etoposide for advanced hepatocellular carcinoma. Oncology 2002;62:293-298.
18. Mathurin P, Raynard B, Dharancy S, Kirzin S, Fallik D, Pruvot FR, Roumilhac D, Canva V, Paris JC, Chaput JC, Naveau S: Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma. Aliment Pharmacol Ther 2003;17:1247-1261.
19. Tanaka K, Shimada H, Togo S, Takahashi T, Endo I, Sekido H, Yoshida T: Use of transcatheter arterial infusion of anti-cancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection. Hepatogastroenterology 1999;46:1083-1088.
20. Fukuda S, Okuda K, Imamura M, Imamura I, Eriguchi N, Aoyagi S: Surgical resection combined with chemotherapy for advanced hepatocellular carcinoma with tumor thrombus: report of 19 cases. Surgery 2002;131:300-310.
21. Ishida H, Iwama T, Mishima Y: The significance of portal vein chemotherapy for liver micrometastases: an experimental study of a rat model. Surg Today 1994;24:900-905.
22. Sargent DJ, Goldberg RM, Jacobson SD, et al: Portal vein chemotherapy for colorectal cancer: a meta-analysis of 4000 patients in 10 studies. J Natl Cancer Inst 1997;89:497-505.
23. Labianca R, Fossati R, Zaniboni A, Torri V: Randomized trial of intraportal and/or systemic adjuvant chemotherapy in patients with colon carcinoma. J Natl Cancer Inst 2004;96:750-758.
24. Fan J, Zhou J, Wu ZQ, et al: Efficacy of different treatment strategies for hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol 2005;11:1215-1219.
25. Konishi M, Ryu M, Kinoshita T, Inoue K: Surgical treatment of hepatocellular carcinoma with direct removal of the tumor thrombus in the main portal vein. Hepatogastroenterology 2001;48:1421-1424.